Kyoto, Japan

Akira Iritani

This inventor holds 1 USPTO granted patent. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Iritani. Retrieved from https://idiyas.com/inventor/akira-iritani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akira Iritani: Innovator in Embryonic Stem Cell Research

Introduction

Akira Iritani is a prominent inventor based in Kyoto, Japan. He is known for his groundbreaking work in the field of embryonic stem cell research. His innovative methods have significant implications for medical and biological studies.

Latest Patents

Iritani holds a patent for a method of producing monkey-origin embryonic stem cells. This patent outlines a process that involves fertilization through in vitro fertilization or intracytoplasmic sperm injection using monkey ova and sperm. The method allows for the differentiation of the fertilized ovum into a blastocyst, which is then used to establish an embryonic stem cell line. The applications of these embryonic stem cells are expected to enhance embryological studies, clinical applications, and experimental models related to primate diseases.

Career Highlights

Iritani is associated with Tanabe Seiyaku Company, Limited, where he contributes to advancements in biomedical research. His work has positioned him as a key figure in the exploration of stem cell applications in various fields.

Collaborations

Iritani has collaborated with notable colleagues, including Norio Nakatsuji and Takashi Tada. Their combined expertise has furthered research in embryonic stem cells and their potential applications.

Conclusion

Akira Iritani's contributions to embryonic stem cell research are invaluable. His innovative methods and collaborations continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…